Dosing Guidelines: CUROSURF® (poractant alfa)

Please see full ISI below, at the end of the above video, and on the website: https://curosurf.com/ Find dosing guidelines for CUROSURF, an intratracheal suspension indicated for the rescue treatment of Respiratory Distress Syndrome (RDS) in premature infants. IMPORTANT SAFETY INFORMATION CUROSURF® (poractant alfa) is intended for intratracheal use only. The administration of exogenous surfactants, including CUROSURF, can rapidly affect oxygenation and lung compliance. Therefore, infants receiving CUROSU

• #فناوری_و_رایانه
• #ldquoneonatal_respiratory_distress_syndromerdquo
• #ldquordsrdquo
• #ldquorespiratory_distress_syndromerdquo